SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883) (BCLI) — Aug 6, 2013

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883)
Date: Aug. 6, 2013 · CIK: 0001137883 · Accession: 0001144204-13-043355

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-186516

Date
August 6, 2013
Author
Managing Director
Form
CORRESP
Company
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) (CIK 0001137883)

Letter

Re: Brainstorm Cell Therapeutics Inc. (the “Company”)

Roth Capital Partners, LLC Maxim Group LLC

888 San Clemente Drive 405 Lexington Avenue, 2nd Floor

Newport Beach, CA 92660 New York, NY 10174

August 6, 2013

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1 (File No. 333-186516)

Ladies and Gentlemen:

In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 4:00 p.m. (New York Time) on Thursday, August 8, 2013, or as soon thereafter as practicable.

In making this request the undersigned acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to the registration statement.

Very truly yours,
Roth Capital Partners, LLC

Show Raw Text
CORRESP
1
filename1.htm

    Roth Capital Partners, LLC
    Maxim Group LLC

    888 San Clemente Drive
    405 Lexington Avenue, 2nd Floor

    Newport Beach, CA  92660
    New York, NY 10174

August 6, 2013

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 Re: Brainstorm Cell Therapeutics Inc. (the “Company”)

Registration Statement on Form S-1
(File No. 333-186516)

Ladies and Gentlemen:

In connection with the above-captioned
registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned
hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 4:00 p.m. (New
York Time) on Thursday, August 8, 2013, or as soon thereafter as practicable.

In making this request the undersigned
acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to
the registration statement.

Very truly yours,

    Roth Capital Partners, LLC

    MAXIM GROUP LLC

    By:
    /s/ Aaron Gurewitz

    By:
    /s/ Eric Cheng

    Name:
    Aaron Gurewitz

    Name:
    Eric Cheng

    Title:
    Head of Equity Capital Markets

    Title:
    Managing Director